Jefferies Financial Group analyst B. Couillard now anticipates that the biotechnology company will earn $0.57 per share for the quarter, down from their prior forecast of $0.70.

Source: https://www.americanbankingnews.com/2023/02/24/brokers-offer-predictions-for-repligen-co-s-q1-2023-earnings-nasdaqrgen.html

“Just seeing these people together to praise people, pray for people that we never met, who served together and left blood on the ground together,” Couillard said.

Source: https://www.postandcourier.com/aikenstandard/news/aiken-residents-veterans-honor-and-remember-on-memorial-day/article_95744ed8-fe45-11ed-a4d5-77e818425d4d.html

The next question will come from Brandon Couillard with Jefferies.

Source: https://seekingalpha.com/article/4580779-repligen-corporation-rgen-q4-2022-earnings-call-transcript?source=feed_all_articles